Liver steatosis in juvenile obesity: Correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test

International Journal of Obesity

Volumn 24, Issue 6, 2000, Pages 772-776

  Guzzaloni, G ^a,c   Grugni, G ^a   Minocci, A ^b   Moro, D ^a   Morabito, F ^a  

^a Divisione Auxologia   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c Ospedale San Giuseppe   (Italy)

Author keywords

Insulin resistance; Lipid profile; Liver steatosis; Obesity; OGTT; Transaminases

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; INSULINEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; ULTRASOUND;

EID: 0034078045     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801224     Document Type: Article

References (46)

1. 1 Van Steenberg W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes 1995; 19(Suppl 3): 27-36.
2. 2 James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353: 1634-1636.
3. 3 Saverymuttu SH, Joseph AEA, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-15.
4. 4 Joseph AEA, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31.
5. 5 Andersen T, Christoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study. Int J Obes 1984; 8: 107-115.
6. 6 Braillon A, Capron JP, Hervé MA, Degott C. Quenum C. Liver in obesity. Gut 1985; 26: 133-139.
7. 7 Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.
8. 8 Luyckx FH, Scheen AJ, Desaive C, Thiry A, Lefebvre PJ. Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplastý-induced weight loss in severe obesity. J Clin Endocrinol Metab 1999; 84: 11.
9. 9 Kral JG, Schaffner F, Pierson RN Jr, Want J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-551.
10. 10 Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990; 11: 224-229.
11. 11 Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224-229.
12. 12 Silverman JF, O'Brien KF, Long S, Leggett N, Khazanic PG, Pories WJ, Norris HT, Caro JF. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastoenterol 1990; 85: 1349-1355.
13. 13 Goto T, Onuma T, Takebe K. Kral JG. The influence of fatty liver on insulin clearance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-845.
14. 14 Galambos JT, Willis CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 1978; 74: 1191-1195.
15. 15 Klain J, Fraser D, Goldstein J, Peiser J, Avinoah E, Ovnat A, Charuzi I. Liver histology abnormalities in the morbid obese. Hepatology 1989; 10: 873-876.
16. 16 Alpers DH, Sabesin SM, White HM. Fatty liver: biochemical and clinical aspects. In L Schiff, ER Schiff (eds). Diseases of liver, Vol II. JB Lippincott: Philadelphia, 1993, pp 825-855.
17. 17 Kusunoky T, Sawada T, Ohya N. Fatty liver associated with simple obesity in childhood. Jpn Med J 1975; 2667: 25-28.
18. 18 Colon A. Hepatic steatosis in children. Am J Gastroenterol 1977; 68: 260-269.
19. 19 Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoky T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3: 408-414.
20. 20 Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239-241.
21. 21 Tominaga K. Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-2009.
22. 22 Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F, Rubino A. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-1432.
23. 23 Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997; 86: 238-241.
24. 24 Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127: 700-704.
25. 25 Bruce R, Godsland I, Walton C, Crook D, Wynn V. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism 1994; 43: 1275-1281.
26. 26 Stromblad G, Bjorntorp P. Reduced hepatic insulin clearance in rats with dietary induced obesity. Metabolism 1986; 323-327.
27. 27 Lee JH, Rhee PL, Lee JK, Lee KT, Kim JJ, Koch KC, Paik SW, Rhee JC, Choi KW. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 1998; 13: 12-14.
28. 28 Ibrahim KM, Nicola WG, Salama SH. Mechanism of insulin resistance and hyperinsulinemia in fattv liver. Boll Chim Farm 1996; 135: 528-540.
29. 29 Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborisaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995; 9: 101-105.
30. 30 Rolland-Cachera MF, Sempé M, Guilloud-Bataille M, Patois E, Péquignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178-184.
31. 31 Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test. Scand J Clin Lab Invest 1985; 45: 741-751.
32. 32 Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10: 167-175.
33. 33 Ibanez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, Carrascosa A. Hyperinsulinism in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996; 81: 1237-1243.
34. 34 Potau N, Ibanez L, Riqué S, Carrascosa A. Pubertal changes in insulin secretion and peripheral insulin sensitivity. Horm Res 1997; 48: 219-226.
35. 35 Iughetti L, Bacchini E, Dodi I, Bianchi A, Caselli G, Cozzini A, Ottaviani A, Bernasconi S. Liver damage and obesity in pediatric age. Pediatr Min Chir 1996; 18: 57-59.
36. 36 Fujisawa T, Uemura H, Inui A, Hanawa Y, Kagimoto S, Fujitsuka S. Clinical observation of the relationship between obesity with fatty liver and obesity without fatty liver. J Jap Pediatr Gastroenterol Nutr 1988; 2: 42-47.
37. 37 Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, Lefebvre PJ. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1988; 22: 222-226.
38. 38 Palmer M, Schaffner F. Effects of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408-1413.
39. 39 Asayama K, Hayashi K, Hayashibe H, Uchida N, Nakane T, Kodera K, Nakazawa S. Relationship between an index of body fat distribution (based on waist and hip circumferences) and stature, and biochemical complications in obese children. Int J Obes 1998; 22: 1209-1216.
40. 40 Day CP, James OFW. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463-1466.
41. 41 Marceau P, Biron S, Hould F-S, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517.
42. 42 Charuzzi I, Klain J, Fraser D, Goldstein J, Ounat A, Peiser J. A scoring system for the prediction of liver histology abnormalities in the morbidly obese. Gastroenterol Clin North Am 1987; 16: 537-539.
43. 43 Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21: 732-737.
44. 44 Phillips DIW, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med 1994; 11: 286-292.
45. 45 Scheen AJ, Paquor N, Letiexhe MR, Paolisso G, Castillo MJ, Lefebvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. Int J Obes 1995; 19 (Suppl 3): 14-20.
46. 46 Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989; 114: 963-967.